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Disruption of T Cell Tolerance to Self-Immunoglobulin Causes
Polyclonal B Cell Stimulation Followed by Inactivation of
Responding Autoreactive T Cells1
Arpita Choudhury, Paushali Mukherjee, Sandip K. Basu, Anna George, Satyajit Rath,2 and
Vineeta Bal2
Scavenger receptor (SR)-specific delivery by maleylation of a ubiquitous self-protein, Ig, to SR-bearing APCs results in self-
limiting induction of autoimmune effects in vivo. Immunization with maleyl-Ig breaks T cell tolerance to self-Ig and causes
hypergammaglobulinemia, with increases in spleen weight and cellularity. The majority of splenic B cells show an activated
phenotype upon maleyl-Ig immunization, leading to large-scale conversion to a CD1381 phenotype and to significant increases in
CD138-expressing splenic plasma cells. The polyclonal B cell activation, hypergammaglobulinemia, and autoreactive Ig-specific T
cell responses decline over a 2-mo period postimmunization. Following adoptive transfer, T cells from maleyl-Ig-immune mice
taken at 2 wk postimmunization can induce hypergammaglobulinemia in the recipients, but those taken at 10 wk postimmuni-
zation cannot. Hypergammaglobulinemia in the adoptive transfer recipients is also transient and is followed by an inability to
respond to fresh maleyl-Ig immunization, suggesting that the autoreactive Ig-specific T cells are inactivated peripherally following
disruption of tolerance. Thus, although autoreactive T cell responses to a ubiquitous self-Ag, Ig, are induced by SR-mediated
delivery to professional APCs in vivo resulting in autoimmune pathophysiological effects, they are effectively and rapidly turned
off by inactivation of these activated Ig-specific T cells in vivo. The Journal of Immunology, 2000, 164: 1713–1721.
T he pathogenesis of diseases considered autoimmune de-pends crucially on the generation of a self-reactive im-mune response despite the presence of mechanisms main-
taining a state of immune self-tolerance. Normally, both the B and
T cells are negatively selected during their development, and au-
toreactive cells can be eliminated by apoptotic deletion (1–4). De-
letional mechanisms operate more stringently for T cells rather
than for B cells (5, 6), and hence the frequency of finding autore-
active B cells in the mature peripheral repertoire is higher than that
for the T cells (6–9). In the periphery, autoreactive mature B and
T cells that have escaped deletion are turned off by a variety of
mechanisms (10–13). Despite multiple mechanisms being avail-
able for silencing autoantigen-specific immunocytes, their pres-
ence can be documented in normal individuals (14, 15), suggesting
leakiness in the mechanisms inducing and maintaining self-toler-
ance. Such autoreactive B and T cell responses can be detected
with increasing frequency in aging populations (16–18), even in
the absence of any demonstrable pathological consequences (15,
18). Thus, autoreactive immunocytes by themselves, even when
triggered in vivo, may not be sufficient for inducing autoimmune
disease.
Naive T cells are activated when professional APCs present Ag
and deliver Ag-nonspecific costimulatory signals (19–21). The
density and duration of availability of peptide-MHC complexes,
which constitute the first signal for T cell activation, have been
suggested to be important for optimal T cell activation (22, 23).
The presence or absence of costimulatory molecules of the B7
family (CD80, CD86) on the priming APCs has also been shown
to modify the outcome of TCR-mediated T cell activation (24–26).
It has been documented that a large proportion of peptides nor-
mally present on MHC molecules are derived from APC endoge-
nous sources (27–29). There have been suggestions that, for those
T cells that have been anergized, the persistent presence of their
target peptide-MHC complexes on peripheral professional APCs is
necessary to maintain a state of anergy (30).
In this context, we have been trying to examine how autoim-
mune T cell responses against a ubiquitous self-Ag induced in vivo
by disrupting normal T cell tolerance are regulated. For this pur-
pose, we have used maleylated self-Ags. Protein maleylation con-
fers on them the ability to bind to scavenger receptors (SRs)3 (31–
33). Although classical SRs are restricted to cells of the monocytic
lineage such as macrophages and dendritic cells (DCs) (33, 34),
other receptor molecules with the ability to bind SR ligands have
also been shown to be present on B cells (34, 35). Thus, protein
maleylation allows the specific delivery and presentation of the
protein to all APC lineages, B cells, macrophages, and DCs (35),
inducing enhanced T cell immunity (36). Using the maleylated
self-Ag mouse serum albumin (MSA) for immunization, we have
shown earlier that an effective T cell response recognizing multiple
MSA-derived peptides can be demonstrated in vitro (37). How-
ever, despite the presence of these activated MSA-specific T cells
as well as of MSA-peptide-loaded APCs, no autoimmune phenom-
ena could be demonstrated in vivo. It was therefore also of interest
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to examine whether this was because the self-reactive T cells trig-
gered by APC-specific delivery of maleylated self-Ags were inca-
pable of functioning in vivo, or because Ag-specific factors deter-
mine the in vivo reactivity and the pathophysiological
consequences of the autoreactive T cells triggered.
In this study, we report use of another self-protein, Ig, which,
unlike MSA, is normally synthesized by one class of MHC class
II-expressing APCs, the B cells. This was also of interest in the
context of the reported data that though naive B cells can induce T
cell anergy (38), activated B cells can break T cell tolerance to a
self-Ag they are specific for (39). Our results using maleyl-Ig as an
immunogen show that self-Ig-specific T cells can be generated in
vivo, that the break in T cell tolerance against Ig causes short-lived
polyclonal B cell activation and hypergammaglobulinemia in vivo,
and that the activated Ig-specific T cells are inactivated following
their triggering.
Materials and Methods
Mice, immunization, and cell transfers
BALB/c mice (The Jackson Laboratory, Bar Harbor, ME), bred in the
small animal facility of the National Institute of Immunology (New Delhi,
India) were used for the experiments. Five to seven mice per group were
immunized i.p. with a single dose of 300 mg of native or maleylated Ag in
PBS or adsorbed on alum (Alhydrogel; Superfos, Vedback, Denmark). For
certain experiments, 300 mg of maleyl-poly-L-lysine-Ig (see method of
preparation below) was mixed with 1 mg of poly(G) or poly(C) (Sigma, St.
Louis, MO) before immunization. Mice were immunized with conalbumin
(CA) or maleylated cytochrome c (cyt-c; Sigma) on alum. 300 mg mouse
i.p., as indicated. Mice were bled from the retro-orbital plexus under in-
halation anesthesia, and sera were used for the estimation of Ab levels.
Mice were killed by cervical dislocation and single-cell suspensions from
spleens were used for flow cytometric analysis, cell fractionation, and T
cell proliferation assays. Where appropriate, various cell combinations
were injected i.p. in syngeneic recipients. The recipients were g-irradiated
(300 rad) BALB/c mice. Wherever appropriate, the recipient mice were
immunized i.p. with maleyl-Ig in PBS (300 mg/mouse). All animal exper-
imentation was done using protocols approved by the Institutional Animal
Ethics Committee.
Chemical modification and conjugation of proteins
Pooled sera of normal BALB/c mice were salt precipitated with 40% am-
monium sulfate, and the precipitate was dissolved in PBS, dialyzed, and
applied to a protein A column (Pharmacia Biotech, Uppsala, Sweden) for
further purification. The protein thus obtained was analyzed on a 10%
reducing SDS-polyacrylamide gel with appropriate m.w. markers to ascer-
tain purity. Protein concentration was estimated with bicinchoninic acid
(Sigma). MSA (Sigma), poly-L-lysine (Sigma), Ig, or cyt-c were maley-
lated with maleic anhydride (Sigma) at alkaline pH as described previously
(40), followed by dialysis against PBS. The degree of maleylation was
estimated from the loss of free e-amino groups measured using trinitro-
benzenesulfonic acid (41). Only protein preparations with .90% maley-
lation were used for the experiments.
Poly-L-lysine or its maleylated form were mixed in a ratio of 3:1 with
Ig and chemical coupling was conducted by adding aqueous glutaraldehyde
(Sigma) dropwise to a final concentration of 0.1%. The conjugates were
used for immunization after extensive dialysis.
T cell proliferation assays
Spleen cells from immune mice were cultured with graded doses of Ag in
96-well flat-bottom microtiter plates (Corning Glass, Corning, NY) at
3–5 3 105 cells/well in 200 ml of L-glutamine-fortified Click’s medium
(Irvine Scientific, Irvine, CA) containing 5 3 1025 M 2-ME (Life Tech-
nologies, Grand Island, NY), antibiotics and 10% FCS (Life Technolo-
gies). The wells were pulsed with 0.5 mCi of [3H]thymidine (New England
Nuclear, Boston, MA) for 12–14 h in a 96-h assay and harvested onto
fiberglass filter mats for scintillation counting (Betaplate; Wallac, Turku,
Finland). Results are expressed as cpm (mean 6 SE) of triplicate cultures.
Triplicate cultures of thymoctes (5 3 105 cells/well) were stimulated by
a submaximal concentration of an anti-CD3e mAb (500-A2; a gift from Dr.
C. A. Janeway, Yale Medical School, New Haven, CT) in the presence of
splenic DC populations isolated from mice treated with carrageenan as
described below or from control mice. The wells were pulsed after 48 h
with [3H]thymidine, and proliferative responses were measured and ex-
pressed as above.
Carrageenan treatment for macrophage depletion
Macrophage depletion in vivo was done by injecting i-carrageenan (CGN;
Sigma) (1 mg/mouse) i.p. every second day (42). On the eighth day, mice
were immunized with Ig or maleyl-Ig as described. The protocol was op-
timized by varying dosage and schedule to ensure complete depletion of
macrophages as judged by absence of Mac-1-bearing cells using anti-
CD11b mAb (TIB128; American Type Culture Collection (ATCC)) in the
spleen on the day of immunization and for 5 succeeding days (data not
shown). This in vivo treatment did not deplete B cells and DCs as seen by
flow cytometry. DCs were also isolated from splenic cells of carrageenan-
treated or control mice on the eighth day as described below and used as
APCs for anti-CD3-induced thymocyte proliferation.
Ab assays
Estimation of total Ig in the sera was done by enzyme immunoassays.
Polyvinyl chloride microtiter plates (Falcon; Becton Dickinson, Lincoln
Park, NJ) were coated with affinity-purified goat anti-mouse Ig (10 mg/ml)
and test sera were titrated. The bound serum Ig was detected by adding goat
anti-mouse Ig peroxidase, followed by o-phenylenediamine (Sigma) and
hydrogen peroxide as revealing agents. Absorbance was read at 492 nm in
a microplate reader (Bio-Tek, Vinooski, VT). For determination of IgM,
goat anti-mouse-IgM peroxidase was used for detection. For estimation of
total IgG, biotinylated anti-mouse-IgG followed by avidin-peroxidase con-
stituted the detection system. For estimation of CA-specific Abs, plates
were coated with CA (10 mg/ml), test sera were titrated, and bound Ig was
detected using goat anti-mouse Ig peroxidase. Concentrations were calcu-
lated, in each instance, on the basis of a known standard titrated in parallel
to the serum samples.
Separation of splenic cell subpopulations
Pooled splenic cells from appropriate groups of mice were incubated on
plastic plates (Corning Glass) for 1 h at 37°C to remove macrophages. The
nonadherent population was separated into B and T cells using magnetic
beads (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the
manufacturer’s instructions. Briefly, the nonadherent population was
stained with anti-B220-biotin on ice for 45 min, washed, and streptavidin-
labeled magnetic beads (Miltenyi Biotec) were added. After a 15-min in-
cubation on ice, the cell suspension was applied to the magnetic column
and nonadherent T cells were washed through into the effluent. The column
was then removed from the magnetic field and adherent B cells were
flushed out. The purity of the separated B and T cell populations was
checked by flow cytometry with anti-B220 for B cells and anti-Thy-1 for
T cells, and was commonly .95%. The separated cell populations were
washed several times with Click’s medium containing 10% FCS. Alterna-
tively, plastic nonadherent splenic cells were loaded onto a nylon wool
column and nylon wool nonadherent cells were collected as T cells,
checked for purity using flow cytometry, and used for additional assays.
Purified T cells from Ig-immune or maleyl-Ig-immune mice and B cells
separated from naive syngeneic mice were mixed in a 3:1 ratio and injected
i.p. into recipient mice where appropriate.
DCs were isolated from carrageenan-treated or control mice using neg-
ative selection by removing cells stained with mAbs against Thy-1, B220,
and Mac-1 followed with goat anti-rat Ig-coated magnetic beads on mag-
netic columns (Miltenyi Biotec). The mAb specific for the B cell-specific
isoform of CD45 (B220), 6B2, the anti-Thy-1 mAb Y-19, and the anti-
Mac-1 mAb M17/4.2 (kind gifts from Dr. C. A. Janeway, Yale Medical
School) were used as culture supernatants.
Flow cytometry
For flow cytometry, cells (1 3 105–1 3 106/well) were incubated with the
primary staining reagents in 100 ml for 45 min on ice. Heat-aggregated
serum of the appropriate species (rat or goat) was used at 1% in the staining
buffer (PBS containing 0.1% sodium azide and 1% BSA) to block Fc re-
ceptors. After washing, a similar procedure was followed for the secondary
and tertiary reagents wherever necessary. The mAb specific for the B cell-
specific isoform of CD45 (B220), 6B2, and the anti-Thy-1 mAb Y-19 were
used as either culture supernatants or in the biotinylated form. IgD expres-
sion and peanut agglutinin (PNA) binding were detected by using fluores-
cein-coupled anti-IgD or PNA (Accurate, San Diego, CA). CD138 was
detected using an anti-CD138 mAb (PharMingen, San Diego, CA). Splenic
DCs were detected using the hamster mAb N418 (HB224; ATCC) and
macrophages by the rat mAb specific for Mac-1, M17/4.2 (TIB217;
ATCC). Primary unlabeled mAbs of rat or hamster origin were detected
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using goat anti-rat or anti-hamster IgG-FITC, respectively, whereas bio-
tinylated reagents were detected using streptavidin-PE (Jackson Immu-
noResearch, West Grove, PA). Stained cells were either analyzed imme-
diately or fixed with 0.1% paraformaldehyde (Sigma) and stored at 4°C
until analyzed on a flow cytometer (Bryte; Bio-Rad, Hemel Hampstead,
U.K.). Data analysis was done with FlowJo software (Treestar, San Jose,
CA), or with WinMDI shareware.
Statistical analysis
Wherever appropriate, statistical analysis was conducted using Student’s
t test.
Results
Immunization with maleyl-Ig breaks T cell tolerance to Ig and
causes hypergammaglobulinemia in vivo
We have shown earlier that immunization with maleyl-MSA re-
sults in a break in T cell tolerance of MSA (37). Whether this was
an exclusive finding for MSA or held true for other ubiquitous
self-proteins was tested using Ig in its native or maleylated form
for immunization. Seven days after immunization with 300 mg of
maleyl-Ig or Ig on alum given i.p., mice were sacrificed. Fig. 1
shows proliferation of splenic cells from mice immunized with
either maleyl-Ig (A) or native Ig (B) in response to titrated Ag
doses. Splenic cells from maleyl-Ig-immune mice responded well
not only to maleyl-Ig but also to Ig, albeit to a lesser extent. In-
terestingly, these cells from individual maleyl-Ig-immune mice
also responded to preimmune serum from the same mouse. In con-
trast, cells from Ig-immune mice did not respond significantly to
any of the three Ags used for recall.
To confirm that the proliferative response induced by maleyl-Ig
was Ag specific and not due to some nonspecific mitogenic effect
of maleyl-Ig, T cells from mice immunized with an unrelated
maleylated self-protein, maleyl-cyt-c, were stimulated with vari-
ous maleylated Ags, self- as well as nonself. Maleyl-Ig did not
evoke any response from maleyl-cyt-c-immune cells despite an
excellent response to maleyl-cyt-c itself (Fig. 1C), confirming, as
we have shown earlier (36), that maleyl proteins do not have non-
specific T cell mitogenic activity. Thus, immunization with ma-
leyl-Ig results in a break in T cell tolerance for self-Ig.
Since Ig-specific T cells can potentially help Ig-expressing B
cells and induce Ig secretion, the levels of total serum Ig in the
maleyl-Ig-immune and Ig-immune groups were examined. Al-
though there was no change in serum Ig levels in Ig-immune mice
at 2 wk postimmunization, the serum Ig levels of maleyl-Ig-im-
mune mice showed a significant ( p , 0.05) increase (Fig. 1D).
However, immunization with maleyl-MSA, which results in a
break in T cell tolerance to MSA (37), did not lead to any increases
in serum Ig levels (Fig. 1D), supporting the notion that the effect
observed is an Ag-specific B cell differentiation to plasma cells and
not a nonspecific inflammatory component of an autoimmune
response.
Targeting of Ags to scavenger receptors in vivo is crucial for a
break in tolerance
In addition to maleylated proteins, SRs bind to many other ligands
(31–33, 40), and we have shown previously that SR-like binding
capabilities are exhibited by all professional APCs (35), although
classical SRs are known to be present only on cells of the mono-
cytic lineage (31, 33, 34). To examine the role of macrophages in
presentation of self-Ags to generate autoimmune responses, we
used CGN to deplete macrophages of their functional capability at
the time of immunization. A week after immunization with maleyl-
Ig, mice were sacrificed and T cell responses to maleyl-Ig were
analyzed. Fig. 2A shows the responses of splenic cells from two
normal mice and two CGN-treated mice immunized with ma-
leyl-Ig 7 days earlier. Although normal mice showed significant
responses to maleyl-Ig, CGN-treated mice mounted very weak re-
sponses to maleyl-Ig immunization. Unlike macrophages, DCs are
not depleted by carrageenan treatment, whereas macrophages are
efficiently depleted (Fig. 2B). We also tested the DCs from carra-
geenan-treated mice to exclude the possibility that they were func-
tionally compromised by carrageenan. DC-enriched cells from car-
rageenan-treated or control mice were equally efficient in
supporting anti-CD3-mediated stimulation of thymocytes (Fig.
2C). This supported the possibility that the partial loss of response
to maleyl-Ig in carrageenan-treated mice was likely to be due to
the absence of macrophages, suggesting that macrophage APCs
may play a significant role in breaking T cell tolerance via maley-
lated self-Ags.
As an alternative approach to maleylation of the immunogen,
unmodified Ig was coupled to either maleylated or unmodified
poly-L-lysine and used as the immunogen (300 mg/mouse in PBS).
Fig. 2D shows that Ig coupled to unmodified poly-L-lysine does
not alter the serum Ig levels in immunized mice. However, like
maleyl-Ig immunization, immunization with Ig coupled to maleyl-
poly-L-lysine induces substantial hypergammaglobulinemia on day
14 postimmunization. Addition of a 3-fold excess of the SR ligand,
poly(G) (40), to the maleyl-poly-L-lysine-Ig during immunization
results in marked inhibition of hypergammaglobulinemia ( p ,
FIGURE 1. Immunization with maleyl-Ig results in autoreactive anti-Ig
T cell responses and hypergammaglobulinemia. Proliferative responses of
splenic cells from maleyl-Ig-immune (A) and Ig-immune (B) mice to ma-
leyl-Ig (E), Ig (M), and autologous preimmune serum (F) are shown. The
background counts were ,3500 cpm. The results are representative of
seven experiments. C, Proliferative responses of splenocytes from maleyl-
cyt-c-immune mice to maleyl-cyt-c (F), maleyl-Ig (E), maleyl-MSA (),
and maleyl-OVA (M). The results are representative of four experiments.
D, Serum Ig levels from Ig-immune, maleyl-Ig-immune, and maleyl-MSA-
immune mice on day 0 (o) and day 14 (f) postimmunization (mean 6
SE). The data represent three independent experiments.
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0.05), whereas addition of a related molecule, poly(C), which is
not an SR ligand (40), does not do so ( p . 0.4), suggesting that
delivery of maleyl-poly-L-lysine-Ig via SRs is likely to be critical
for the effects seen in vivo.
Maleyl-Ig immunization leads to polyclonal B cell activation
in vivo
The Ig isotypes affected by hypergammaglobulinemia were next
examined, and it can be seen that both IgM and IgG levels went up
at 2 wk postimmunization in maleyl-Ig-immune mice (Fig. 3A) as
compared with those seen in Ig-immune mice ( p , 0.01). Since
both primary and secondary Ig isotypes are affected, the B cell
stimulation observed is likely to be T cell dependent. In addition to
the hypergammaglobulinemia, on day 7 postimmunization, spleens
from maleyl-Ig-immune mice showed an increase in weight ( p ,
0.01) as well as cellularity ( p , 0.05) as seen in Fig. 3.
If the serum hypergammaglobulinemia seen in maleyl-Ig-im-
mune mice is the result of activated Ig-specific T cells triggering
Ig-presenting B cells in vivo, practically all B cells in these mice
would be expected to be affected. To test this directly, we next
examined the phenotype of splenic B cells by two-color flow cy-
tometry. Splenic cells from maleyl-Ig-immune or Ig-immune mice
were stained 1 wk postimmunization for the B cell marker B220 vs
IgD or PNA reactivity as markers of B cell activation. Fig. 4A
shows that there was a significant reduction in the proportion of
IgD-bearing B cells in maleyl-Ig-immune mice (b) in comparison
to their Ig-immunized counterparts (a), although the frequency of
total splenic B cells was not significantly altered. Since IgD is
normally down-regulated by naive B cells upon T-dependent ger-
minal center activation (43), this suggested that most naive B cells
in the spleens of maleyl-Ig-immune mice were receiving activation
signals.
FIGURE 2. Break in tolerance to Ig is dependent on targeting of Ig to
SR-bearing APCs such as macrophages. A, Responses of individual ma-
leyl-Ig-immune mice to maleyl-Ig when mice were pretreated (broken line)
or not pretreated (continuous lines) with CGN. Background counts were
7000–8000 cpm. The results are representative of two independent exper-
iments. B, Flow cytometric analysis of spleen cells from mice pretreated
(thick lines) or not pretreated (thin lines) with CGN, stained for either
Mac-1 or the DC marker N418 as indicated. Negative control curves are
shown in gray. The results are representative of five separate experiments.
C, Response of thymocytes to anti-CD3e in the presence of titrating num-
bers of DCs from mice pretreated (broken line) or not pretreated (contin-
uous line) with CGN. Background counts were 3000–5000 cpm. The data
are representative of two experiments. D, Serum Ig levels (mean 6 SE, for
five mice per group) on day 0 (o) and day 14 (f) postimmunization from
variously immunized mice as shown. Data represent three independent
experiments.
FIGURE 3. Break in tolerance to Ig results in B cell activation in vivo.
A, IgM and IgG levels (mean 6 SE) on day 0 (o) and day 14 (f) postim-
munization from Ig-immune and maleyl-Ig-immune mice. B, Average
spleen weight (mean 6 SE). C, Spleen cell counts (mean 6 SE) from
various groups on day 7 postimmunization. The data represent four inde-
pendent experiments.
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An increase in the ability to bind to the lectin PNA normally
accompanies T-dependent B cell activation and germinal center
formation, and PNA binding is in fact treated as a hallmark of
germinal center B cells (43). As seen in Fig. 4A, while only a
minor proportion of B cells in Ig-immune mice were PNA1, the
majority of B cells in the maleyl-Ig-immune mice acquired PNA-
binding capabilities (d), although the frequency of total splenic B
cells was again unchanged. Thus, soon after immunization, before
the peak of hypergammaglobulinemia is reached, the majority of
splenic B cells in maleyl-Ig-immune mice are in an activated state.
Activation of B cells must lead to their differentiation into
plasma cells before they can secrete large quantities of Ig (44). To
investigate whether most B cells triggered by Ig-specific autore-
active T cells activated by maleyl-Ig immunization went on to give
rise to plasma cells, CD138 was used as a marker for plasma cells
in flow cytometric analyses (45–47). Fig. 4B shows a two-color
analysis for B220 and CD138 in Ig-immune ( plots e and g) and
maleyl-Ig-immune ( plots f and h) mice on day 7 and day 14
postimmunization. There were very few CD1381 splenic cells in
the Ig-immune mice at either time point. In sharp contrast, maleyl-
Ig-immune mice had a large proportion of their B2201 cells ex-
pressing CD138 on day 7, although there were no classical
CD1381B2202 plasma cells seen. By day 14 postimmunization
with maleyl-Ig, however, such B2202 plasma cells had become a
major population (20%) in the spleen, and the frequency of B2201
B cells had concomitantly declined. These data suggest that poly-
clonal B cell activation by autoreactive T cells in maleyl-Ig-im-
mune mice progresses to terminal plasma cell differentiation of the
majority of activated B cells.
Maleyl-Ig-induced hypergammaglobulinemia and polyclonal B
cell activation is short-lived in vivo
To examine the course of the putative autoimmune effects ob-
served in vivo, maleyl-Ig-immune mice were bled sequentially and
serum Ig levels were estimated. By day 42 postimmunization with
maleyl-Ig, serum Ig levels had returned to normal (Fig. 5A). By 10
wk postimmunization, splenic weight and cellularity were again
comparable between Ig-immune and maleyl-Ig-immune groups
(Fig. 5B). The phenotypic changes in B cells observed at early time
points also disappeared by this time as shown in Fig. 5C. The
frequency of IgD-expressing B2201 B cells in maleyl-Ig-immune
spleen cells (Fig. 5C, b) was now only marginally lower than that
in control Ig-immune spleen cells (Fig. 5C, a), and there was little
difference between the PNA-binding B cell frequencies in the two
groups (Fig. 5C, c and d). Thus, the presence of activated splenic
B cells in maleyl-Ig-immune mice decreases in concordance with
the reduction in the serum hypergammaglobulinemia.
Functional inactivation of Ig-specific T cells in vivo over time
We next investigated whether Ig-specific T cells that are presum-
ably responsible for the observed hypergammaglobulinemia per-
sist in vivo. Splenocytes from mice immunized with Ig or ma-
leyl-Ig and sacrificed on day 70 postimmunization showed hardly
FIGURE 4. Most splenic B cells in maleyl-Ig-immune mice show an
activated phenotype. A, Two-color flow cytometric analysis for B220 vs
either IgD (plots a and b) or PNA (plots c and d) on day 7 postimmuni-
zation. Plots a and c, Staining from Ig-immune and plots b and d from
maleyl-Ig-immune mice. B, A similar analysis for B220 vs CD138 on day
7 (plots e and f) and day 14 (plots g and h) postimmunization on splenic
cells from Ig-immune (plots e and g) and maleyl-Ig-immune (plots f and h)
mice. Numbers in various compartments show percentages of cells. Results
represent four independent experiments.
FIGURE 5. Effects of break in Ig-specific T cell tolerance are transient
in nature. A, Serum Ig levels (mean 6 SE) in maleyl-Ig-immune mice over
a period of 9 wk. B, Spleen weight and cellularity in Ig-immune and
maleyl-Ig-immune mice on day 70 postimmunization. C, The phenotype of
splenic B cells from Ig-immune and maleyl-Ig-immune mice on day 70
postimmunization. Two-color staining patterns are shown for B220 vs IgD
(a and b) or B220 vs PNA (c and d) from Ig-immune (a and c) or maleyl-
Ig-immune (b and d) mice. Numbers in various compartments show per-
centage of cells. The data are representative of three independent
experiments.
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any response to in vitro stimulation with Ig or maleyl-Ig (Fig. 6A).
Although T and B cell numbers are normal in mice immunized
with Ig or maleyl-Ig on day 70 postimmunization (data not shown),
it is possible that they may not be functionally normal. We exam-
ined the ability of these mice to respond to an unrelated Ag, CA.
Fourteen days after immunization with CA on alum, mice from
Ig-immune and maleyl-Ig-immune groups showed comparable
levels of CA-specific Ab responses (Fig. 6B) as well as in vitro T
cell-proliferative response (Fig. 6C), suggesting that the loss of
autoreactivity-associated phenomena was due to a specific func-
tional loss of autoreactive T cells rather than to any global alter-
ation in the functionality of the T or the B cell compartments.
To analyze the abilities of Ig-specific T cells to induce poly-
clonal activation of naive B cells in vivo and to study their fate, T
cells purified from Ig-immune or maleyl-Ig-immune mice 14 or 70
days after immunization were adoptively transferred along with
normal B cells into syngeneic g-irradiated recipients. The serum Ig
levels in the recipients were then monitored over time. Fig. 6D
shows that although mice receiving T cells from day 14 maleyl-
Ig-immune donors showed marked hypergammaglobulinemia
( p , 0.05), mice receiving T cells from day 70 maleyl-Ig-immune
donors or from both days 14 and 70 Ig-immune donors showed
normal Ig levels. These data indicate that only T cells from day 14
maleyl-Ig-immune mice are capable of triggering naive B cells to
produce hypergammaglobulinemia.
The serum hypergammaglobulinemia seen in mice receiving
day 14 T cells from maleyl-Ig-immune donors declined over time
(Fig. 7) and by day 42 serum Ig levels had returned to pretransfer
levels (data not shown), whereas there was no change in serum Ig
levels in the day 14 Ig-immune T cell recipients. Both of these
groups were then immunized with 300 mg/mouse of maleyl-Ig and
serum Ig levels were estimated 7 days later. Interestingly, recipi-
ents of maleyl-Ig-immune T cells did not show any change in
serum Ig levels (Fig. 7), whereas recipients of Ig-immune T cells
showed distinct hypergammaglobulinemia ( p , 0.02), suggesting
that once triggered by maleyl-Ig, Ig-specific T cells respond and
cause polyclonal B cell stimulation, but at the same time become
rapidly inactivated themselves.
Discussion
We have shown earlier that SR-mediated delivery of foreign pro-
tein Ags results in the enhancement of immunogenicity (36), and
that the immune responses so generated show a relative Th1 dom-
inance (35). The peptide repertoires generated from native protein
and maleylated protein are largely cross-reactive (35). Those re-
sults suggested that higher densities of peptide-MHC complexes
generated on all three major APC types, B cells, macrophages, and
dendritic cells, and/or their persistence for longer periods in vivo
may be relevant factors for regulating the type of immune response
triggered. We had also shown previously that SR-mediated deliv-
ery of maleylated MSA can activate self-albumin-specific T cells
(37), suggesting that such APC-targeted high-efficiency delivery of
self-Ags may be instrumental in overcoming T cell tolerance.
However, in spite of the presence of MSA-reactive T cells in vivo,
no signs of autoimmune phenomena could be detected in these
mice in vivo. One reason for this could be that the autoreactive T
cells generated by maleylated self-protein immunization are poor-
efficiency low-affinity leftovers from negative selection that can
show some evidence of activation under ideal conditions in vitro
but cannot function in vivo. An alternative possibility was that
anti-self-albumin T cell responses do not cause autoimmune con-
sequences in vivo because of the possibly restricted distribution of
their peptide-MHC ligands, but that a similar break in T cell tol-
erance against some other self-Ags may do so. To test this possi-
bility, we chose another ubiquitous self-protein, Ig, which, unlike
FIGURE 6. Specific loss of Ig-specific T cell function in vivo. A, T
cell-proliferative responses in vitro from Ig-immune (F) or maleyl-Ig-im-
mune (E) mice to titrating doses of Ag either on day 8 (continuous lines)
or day 70 (broken lines) postimmunization. B, Serum anti-CA Ab levels
(mean 6 SE) in Ig-immune or maleyl-Ig-immune mice immunized with
CA-alum on day 70 after Ig or maleyl-Ig immunization, respectively. C,
The anti-CA-proliferative responses from the CA-immunized mice in B,
preimmunized with either Ig (F) or maleyl-Ig (E). D, Serum Ig levels in
irradiated syngeneic recipients after adoptive cell transfer. Ig levels
(mean 6 SE) in recipient mice before transfer (2) and 7 days after transfer
of normal B cells with T cells from the various groups are shown. Data are
representative of three independent experiments.
FIGURE 7. Ig-specific T cells are inactivated in vivo after maleyl-Ig
immunization. Serum Ig levels (mean 6 SE) are shown at various times in
recipients after receiving normal B cells and T cells from either Ig-immune
(o) or maleyl-Ig-immune (shaded bars) mice 14 days after immunization.
The last point in the series indicated by 421 [7] and bold bars indicates
serum Ig levels in the recipients 7 days after they were immunized with
maleyl-Ig on day 42 posttransfer. Data represent three independent
experiments.
1718 INACTIVATION OF AUTOREACTIVE T CELLS AFTER BREAK IN TOLERANCE
 o
n
 A
ugust 12, 2010 
w
w
w
.jimmunol.org
D
ow
nloaded from
 
MSA, is synthesized and presented with high efficiency (48) by
one class of professional APCs, B cells. Our results presented here
show that maleyl-Ig-immune mice show not only a break in T cell
tolerance detectable in vitro, but also show autoimmune conse-
quences in vivo, although these autoimmune responses are
short-lived.
As a self-Ag source, we have used Ig isolated from pooled syn-
geneic serum of BALB/c mice. However, it is quite possible that
there would be idiotypic differences in Ig from individual mice,
and therefore such pooled syngeneic Ig may be part “foreign” to
any recipient of immunization. Therefore, in addition to using
pooled Ig in both native and maleylated forms as recall Ags in
vitro, we used preimmune autologous serum from each individual
mouse as an additional source of Ig that would be completely self.
Splenic cell proliferation assays done individually in this fashion
unequivocally demonstrate break in tolerance to self-Ig (Fig. 1).
We have previously shown that maleylated foreign proteins are not
nonspecific mitogens for T cells, and the data shown in Fig. 1C
confirm that this is true for maleyl-Ig as well.
The results from our previous experiments with triggering T cell
autoreactivity to mouse albumin suggested that the presence of
activated albumin-reactive T cells in these mice had no discernible
pathophysiological consequences. The trivial explanation for this
would have been that the autoreactive T cells triggered by maley-
lated self-protein immunization are low-affinity, low-efficiency
cells that have no physiological significance. The fact that ma-
leyl-Ig immunization leads to increased serum Ig levels in vivo
(Fig. 1D), although immunization with maleyl-MSA does not, sug-
gests that the trivial explanation is not tenable. It is much more
likely that such autoreactive T cells are indeed capable of func-
tioning in vivo, and that the identity of the self-protein concerned
is decisive in determining the extent and outcome of their activity
in vivo. The hypergammaglobulinemia is likely to be the result of
polyclonal activation of B cells regardless of their antigenic spec-
ificity, since the levels of maleyl-Ig-specific Abs generated (,50
mg/ml; data not shown) are far lower than the increases observed
in serum Ig levels. One potential implication of this finding is that
Ig-derived peptide-MHC complexes are presented far more effi-
ciently by B cells than MSA-derived peptide-MHC complexes are,
despite the high concentrations of circulating serum albumin, rais-
ing issues of the relative efficiency of natural peptide generation
from APC-endogenous vs APC-exogenous sources.
For SR-mediated uptake, Ags in solution form are delivered
efficiently. We have used alum as an adjuvant in some of the
present experiments (Fig. 1), since we have observed that adsorp-
tion of maleylated foreign proteins on alum still leads to increased
uptake into and presentation by macrophages as well as to en-
hanced immunogenicity and a Th1 cytokine bias (data not shown).
However, similar results have also been observed with immuniza-
tion using maleyl-Ig in PBS alone (Fig. 2). We have also shown
previously that, in addition to macrophages, some DCs and most B
cells can bind to SR ligands such as maleylated proteins and
present them to T cells (35). DCs are considered essential and
sufficient APCs to prime for foreign Ags (49, 50). The APC re-
quirements for the present break in tolerance are not clear. It was
therefore of interest to ask whether macrophage depletion in vivo
could alter the efficiency of this break in tolerance. Since CGN is
known to deplete macrophages in vivo (42, 51), we immunized
mice with maleyl-Ig during a period when splenic macrophages
were eliminated by CGN treatment, leaving DC and B cell popu-
lations unaffected (data not shown). The results show (Fig. 2A) that
macrophage depletion results in a decrease in the degree of auto-
reactivity triggered by maleyl-Ig (Fig. 2A) and maleyl-MSA (data
not shown). The use of desulfated CGN, which induces less tox-
icity and affects macrophages more specifically than CGN (42, 51),
gave similar results, both for maleyl-Ig and maleyl-MSA (data not
shown). Despite macrophage depletion, carrageenan-treated mice
immunized with maleyl-Ig do show some T cell-proliferative re-
sponses in vitro (Fig. 2A), possibly due to the fact that while DCs
are not numerically or functionally affected by CGN treatment
(Fig. 2, B and C), only a subpopulation of DCs shows the ability
to bind maleylated proteins (35), possibly leading to poorer DC-
mediated uptake and presentation of maleyl-Ig to T cells. These
data suggest that functional macrophages contribute significantly
to deliver and/or amplify the tolerance-breaking signals to autore-
active T cells, although it is not yet clear whether this is mediated
by simply larger amounts of peptide-MHC complexes being gen-
erated or by alterations dependent on costimulatory signals specific
to macrophages.
Using maleylated Ig to break T cell tolerance to Ig raises the
possibility that new epitopes generated on the modified Ig mole-
cule may in part be responsible for the triggering of autoreactivity,
and that the SR-specific delivery may not be crucial. Therefore, we
used an alternate modality of Ig delivery to SRs without maleyla-
tion of the Ig itself by coupling it to a carrier without any T cell
epitopes, poly-L-lysine, that could be maleylated for SR-specific
delivery. Maleyl-poly-L-lysine-coupled Ig did indeed induce hy-
pergammaglobulinemia whereas poly-L-lysine-coupled Ig did not,
and the need for specific delivery of Ig to SR-bearing APCs for
inducing a break in tolerance is clearly shown by the competition
in vivo of maleyl-poly-L-lysine-Ig with poly(G) (but not poly(C))
leading to reduced hypergammaglobulinemia (Fig. 2D).
Since mice showing a break in T cell tolerance for autologous Ig
show significant increases in their serum Ig levels, it appears that
once triggered, Ig-specific T cells can recognize Ig-derived pep-
tide-MHC complexes on B cells and activate them. Because it is
quite possible that the self-Ig peptides being recognized by these
autoreactive T cells are invariant, a single Ig-specific T cell may be
able to activate many B cells presenting the same Ig-derived pep-
tide, resulting in B cell differentiation causing hypergammaglobu-
linemia. This activation appears to extend to isotype switching,
since both IgM and IgG levels in serum are elevated (Fig. 3). The
extent of hypergammaglobulinemia is comparable between vari-
ous IgG subclasses (data not shown), emphasizing the diversity of
B cells being activated. Also, the weight and the cellularity of the
spleen increase in maleyl-Ig-immune mice (Fig. 3), further rein-
forcing the extensive nature of the alterations taking place in vivo.
The polyclonality of the B cells being activated is also evident
in the phenotypic characterization of splenic B cells (Fig. 4).
Within a few days of maleyl-Ig immunization, most splenic B cells
down-modulate their surface IgD and acquire increased PNA-
binding capabilities, showing that they are being activated by T
cells. In addition, many of these B cells begin to coexpress the
plasma cell marker CD138, indicating that they may be in transi-
tion to plasma cell differentiation. In fact, by day 14 postimmuni-
zation, this process appears to be well advanced, since the propor-
tion of B cells in the spleen dwindles and B2202 plasma cells
become a prominent population (Fig. 4). Thus, maleyl-Ig-triggered
Ig-specific T cells appear to be responsible for T-dependent acti-
vation of most B cells, leading to hypergammaglobulinemia within
2 wk after immunization.
However, despite the continuous presence of endogenous Ag
available for triggering Ig-specific T cells, the hypergammaglobu-
linemia is transient (Fig. 5A) as are the splenic hypercellularity
(Fig. 5B) and the activated phenotype of splenic B cells (Fig. 5C).
There are no further pathological consequences such as renal dam-
age that we have been able to observe in these mice either (data not
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shown), possibly owing to the transient nature of the hypergam-
maglobulinemia. In fact, the rate of decline of the serum Ig levels
is rapid enough that, considered together with the known half-life
of circulating Ig, it is possible that all B cells responding in a small
time window go through terminal differentiation to plasma cells.
This transience appears to be a consequence of the rapid loss of
functional Ig-specific autoreactive T cells, so that by 10 wk
postimmunization, there are no T cells in the mice that can either
proliferate in response to self-Ag or provide help to B cells (Fig.
6). Thus, once the initial B cells activated by triggered Ig-specific
T cells have gone to terminal plasma cell differentiation, the new
B cell populations emerging from the bone marrow are no longer
stimulated by autoreactive T cells. These B cells, which show a
normal phenotype at day 70 postimmunization, are functionally
normal, since they respond normally to further immunization with
a T-dependent protein Ag (Fig. 6B).
The adoptive transfer experiments demonstrate that the Ig-spe-
cific autoreactive T cells induced by maleyl-Ig immunization can
drive normal B cells to Ig secretion without the continuing pres-
ence of maleyl-Ig (Fig. 6D). These experiments are also supported
by data on adoptive transfer of T cells from variously immunized
donors into nude mice (data not shown). However, this property is
lost by 10 wk postimmunization, so that there seem to be no au-
toreactive Ig-specific T cells left by this time point (Fig. 6D). In
fact, reimmunization of the recipients shows that, although a trans-
ferred naive T cell repertoire (from the Ig-immunized mice) is
perfectly capable of responding against a first exposure to maleyl-
Ig, previous experience with maleyl-Ig renders the T cells taken
from maleyl-Ig-immune mice unable to mount an autoreactive re-
sponse again (Fig. 7). Clearly, the induction of anti-Ig T cell au-
toreactivity is followed by rapid inactivation of the Ig-specific T
cells making the mice tolerant to further autoimmunization. Pe-
ripheral induction of T cell tolerance following activation has been
documented in many instances such as with superantigens (52, 53)
where T cell activation is followed by clonal exhaustion and apo-
ptotic cell death. It is quite plausible that presentation of Ig-derived
peptides in large amounts by activated B cell APCs might result in
hyperstimulation of Ig-specific T cells leading to similar functional
inactivation. However, it is also possible that autoreactive T cells
are being subjected to some regulatory mechanism such as “infec-
tious tolerance” (54), since the maleyl-Ig-specific T cell response
triggered in the recipients from the reconstituting endogenous T
cells appears to be poor even 42 days after transfer (Fig. 7).
These data clearly show that immunization with a maleylated
self-protein can bring about a break in T cell self-tolerance with
autoimmune consequences in vivo. Whether the Ag is endogenous
to professional APCs or not may be an important factor for deter-
mining the pathologic effects of such a break in tolerance. How-
ever, the very fact that endogenous Ag is presented in high enough
concentrations to induce detectable effects in vivo may lead to
clonal exhaustion of the autoreactive T cells, limiting the duration
of the consequences induced. It is attractive to speculate that this
may be a factor contributing to the relapse and remission progres-
sion of many autoimmune diseases.
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